article thumbnail

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

Cannabis Law Report

NEW YORK , June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Date and Time: Available Starting June 4, 2021 , 9:00 am (EST).

Data 100
article thumbnail

Psymposia Report: MAPS Canada’s Data Breach Foreshadows Corporadelic Future

Cannabis Law Report

Psymposia report… O n Sep 23, 2021, Psymposia staff received an email from the personal email account of Mark Haden — the former Executive Director of psychedelic nonprofit MAPS Canada and current Director of Clinical Trials for Psygen Inc. MAPS Canada’s Data Breach Foreshadows Corporadelic Future. Read full report.

Data 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Leadership & Product Launch Event in Prague

Cannabis Law Report

(OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will host its Europe Regional Event in Prague on March 5 and 6, 2022. billion in 2021.

Events 52
article thumbnail

IRI Thought Leaders to Discuss New Trends and Research at Several Upcoming Industry Events

Cannabis Law Report

14, 2021, from 11:00 a.m. NGA Show 2021. . 19, 2021, 5:45 – 6:45 p.m. 21, 2021, at 11:00 a.m. 22, 2021, from 11:00 a.m. ARF AUDIENCExSCIENCE 2021. . This bodes well for traditional cannabis product food and beverage processors as well as active CPG giants already exploring the market. . .

Events 102
article thumbnail

SOL Global Provides Interim Unaudited Financials for the Second Quarter Ended May 2021

Cannabis Law Report

. (“ SOL Global ” or the “ Company “) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to provide its investors with unaudited financials for the second quarter ended May 31, 2021, and other highlights for the interim period. million for the six-months ended May 31, 2021, compared to $27.4 at May 31, 2020.

Events 105
article thumbnail

Cannabis Conference Announces Education Program for In-Person Event: Aug. 24-26 in Las Vegas

SpeedWeed

LAS VEGAS, NV (March 4, 2021) – Cannabis Conference (August 24-26, 2021, at the Paris Las Vegas Hotel & Casino) today announces its education program, which includes 45+ sessions within four education tracks that will provide actionable takeaways about the most pressing issues plant-touching businesses currently face in the cannabis industry.

article thumbnail

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Cannabis Law Report

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.